Specification Change for Cardilostat. Analytical Method Change for Cardilostat — routine update. Impacts 8 markets and 4 variations.

Change Number
CHG-2022-0003
Type
Specification Change
Status
Pending
Owner
Dmitri Volkov
Initiated
2022-05-29
Description

Analytical Method Change for Cardilostat — routine update

Impacted Markets (8)
CN — ChinaBR — BrazilCH — SwitzerlandDE — GermanyIN — IndiaPL — PolandBE — BelgiumAT — Austria
Impacted Modules
2.3.P
Linked Variations (4)
Variation #TypeApplicationStatusSubmittedApproved
TFDA-2024-0011-V011Type IBTFDA-2024-0011Approved—2024-03-29
HSA-2023-0012-V012Type IAHSA-2023-0012Overdue——
CDSCO-2022-0013-V013Type IICDSCO-2022-0013Overdue——
COFEPRIS-2021-0014-V014Type IBCOFEPRIS-2021-0014Completed2023-11-24—